PGP and B-cell non-Hodgkin lymphoma: Pretreatment sTK1 activity was higher in dogs with B-cell lymphoma (P < 0.001), in dogs with clinical substage b (P = 0.025) and in dogs with Pgp-overexpressing lymphoma (P = 0.013).